股本结构

单位:万股
公告日期 2025-11-05 2025-11-05 2025-08-06 2025-08-06 2025-05-07 2025-05-07
证券总股本 5405.65 5380.60 5323.69 5299.40 5250.24 5217.50
普通股本 5405.65 5380.60 5323.69 5299.40 5250.24 5217.50
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2025-10-31 2025-09-30 2025-07-31 2025-06-30 2025-04-30 2025-03-31
注释:中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本(万股) 变动后优先股(万股) 变动原因 变动日期
2025-11-05 5405.65 未披露 定期报告 2025-10-31
2025-11-05 5380.60 未披露
更多>>
From June 30, 2025 to September 30, 2025 Settlement of restricted stock
2025-09-30
2025-08-06 5323.69 未披露 定期报告 2025-07-31
2025-08-06 5299.40 未披露
更多>>
From March 31, 2025 to June 30, 2025 Issuance of common stock pursuant to the 2018 ESPP (as defined below) Settlement of restricted stock
2025-06-30
2025-05-07 5250.24 未披露 定期报告 2025-04-30
2025-05-07 5217.50 未披露
更多>>
From December 31, 2024 to March 31, 2025 Settlement of restricted stock
2025-03-31
2025-04-03 5217.45 未披露 定期报告 2025-03-26
2025-03-12 5208.52 未披露 定期报告 2025-02-28
2025-03-12 5125.70 未披露
更多>>
From December 31, 2023 to December 31, 2024 Issuance of restricted stock Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) Exercise of common stock options Issuance of common stock, net of issuance cost Issuance of common stock pursuant to the 2018 ESPP (as defined below)
2024-12-31
2024-11-06 5082.24 未披露 定期报告 2024-10-31
2024-11-06 5034.20 未披露
更多>>
From June 30, 2024 to September 30, 2024 Settlement of restricted stock
2024-09-30
2024-08-07 4984.01 未披露 定期报告 2024-07-31
2024-08-07 4940.20 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common stock pursuant to the 2018 ESPP (as defined below) Settlement of restricted stock
2024-06-30
2024-05-08 4878.30 未披露 定期报告 2024-04-30
2024-05-08 4817.40 未披露
更多>>
From December 31, 2023 to March 31, 2024 Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) Exercise of common stock options Settlement of restricted stock Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)
2024-03-31
2024-04-12 4817.37 未披露 定期报告 2024-03-26
2024-03-14 4410.91 未披露 定期报告 2024-02-29
2024-03-18 3972.83 未披露
更多>>
From December 31,2022 to December 31,2023 Exercise of common stock options Issuance of restricted stock Issuance of common stock Issuance of common stock under the ESPP
2023-12-31
2023-11-08 3925.41 未披露 定期报告 2023-10-31
2023-11-08 3852.80 未披露
更多>>
From June 30, 2023 to September 30, 2023 Exercise of common stock options Settlement of restricted stock
2023-09-30
2023-08-01 3772.42 未披露 定期报告 2023-07-31
2023-05-04 3390.82 未披露 定期报告 2023-04-30
2023-05-04 3364.50 未披露 定期报告 2023-03-31
2023-04-10 3367.05 未披露 定期报告 2023-03-27
2023-04-10 3363.84 未披露 定期报告 2023-03-01
2023-03-01 3360.58 未披露 定期报告 2023-02-28
2023-03-01 3347.70 未披露
更多>>
From December 31, 2021 to December 31, 2022 Exercise of common stock options Issuance of restricted stock Common stock to be issued for the acquisition of Entertainment Issuance of common stock under the ESPP Repurchase and Cancellation of common stock
2022-12-31
2022-11-01 3316.58 未披露 定期报告 2022-10-31
2022-11-01 3304.30 未披露
更多>>
From June 30, 2022 to September 30, 2022 Settlement of restricted stock
2022-09-30
2022-08-02 3289.38 未披露 定期报告 2022-07-31
2022-08-02 3288.30 未披露
更多>>
From March 31, 2022 to June 30, 2022 Exercise of common stock options Settlement of restricted stock Issuance of common stock pursuant to the ESPP Repurchase and cancellation of common stock
2022-06-30
2022-05-02 3411.51 未披露 定期报告 2022-04-30
2022-05-02 3379.00 未披露
更多>>
From December 31, 2021 to March 31, 2022 Exercise of common stock options Settlement of restricted stock Common stock purchase consideration for the acquisition of Entertainment
2022-03-31
2022-04-11 3374.90 未披露 定期报告 2022-03-01
2022-03-01 3374.27 未披露 定期报告 2022-02-28
2022-03-01 3353.40 未披露
更多>>
From December 31, 2020 to December 31, 2021 Exercise of common stock options Issuance of restricted stock Issuance of common stock Common stock purchase consideration for the acquisition of Dosh Issuance of ESPP
2021-12-31
2021-11-02 3326.92 未披露 定期报告 2021-10-31
2021-11-02 3315.40 未披露
更多>>
From June 30, 2021 to September 30, 2021 Exercise of common stock options Settlement of restricted stock Common stock purchase consideration for the acquisition of Dosh
2021-09-30
2021-08-03 3304.01 未披露 定期报告 2021-07-31
2021-08-03 3302.30 未披露
更多>>
From December 31, 2020 to June 30, 2021 Issuance of restricted stock Issuance of common stock Issuance of common stock pursuant to the ESPP Common stock purchase consideration for the acquisition of Dosh
2021-06-30
2021-05-04 3287.61 未披露 定期报告 2021-04-30
2021-05-04 3177.00 未披露
更多>>
from December 31, 2020 to March 31, 2021 Exercise of common stock options Issuance of restricted stock Issuance of common stock
2021-03-31
2021-04-06 3176.98 未披露 定期报告 2021-03-29
2021-03-05 3171.07 未披露
更多>>
1.Common Stock offered by the company 3,850,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 27,860,729 shares of common stock outstanding as of December 31, 2020.
2021-03-05
2021-04-06 2790.41 未披露 定期报告 2021-03-01
2021-03-01 2790.38 未披露 定期报告 2021-02-28
2021-03-01 2786.07 未披露
更多>>
From December 31, 2019 to December 31, 2020 Exercise of common stock options Exercise of common stock warrants Issuance of restricted stock Issuance of ESPP
2020-12-31
2020-11-02 2746.44 未披露 定期报告 2020-10-31
2020-11-02 2654.70 未披露
更多>>
From June 30, 2020 to September 30, 2020 Exercise of common stock options Settlement of restricted stock
2020-09-30
2020-08-04 2728.61 未披露 定期报告 2020-07-31
2020-08-04 2727.50 未披露
更多>>
From March 31, 2020 to June 30, 2020 Exercise of common stock options Settlement of restricted stock Issuance of common stock pursuant to the ESPP
2020-06-30
2020-05-11 2696.76 未披露 定期报告 2020-04-30
2020-04-20 2695.60 未披露 定期报告 2020-04-06
2020-05-11 2682.40 未披露
更多>>
From December 31, 2019 to March 31, 2020 Exercise of common stock options Exercise of common stock warrants Settlement of restricted stock
2020-03-31
2020-03-03 2670.45 未披露 定期报告 2020-02-28
2020-03-03 2654.70 未披露
更多>>
from December 31, 2018 to December 31, 2019 Exercise of common stock options Exercise of common stock warrants Issuance of restricted stock Issuance of common stock Issuance of ESPP
2019-12-31
2019-11-12 2571.17 未披露 定期报告 2019-10-31
2019-11-12 2566.40 未披露
更多>>
from June 30, 2019 to September 30, 2019 Exercise of common stock options Exercise of common stock warrants Settlement of restricted stock Issuance of common stock
2019-09-30
2019-09-13 2432.77 未披露 定期报告 2019-09-13
2019-08-08 2284.21 未披露 定期报告 2019-07-31
2019-08-08 2282.80 未披露
更多>>
from March 31, 2019 to June 30,2019 Issuance of ESPP Exercise of common stock options Settlement of restricted stock
2019-06-30
2019-04-30 2256.95 未披露 定期报告 2019-04-26
2019-04-30 2256.95 未披露 定期报告 2019-04-01
2019-05-09 2257.00 未披露
更多>>
from December 31, 2018 to March 31, 2019 Exercise of common stock options Settlement of restricted stock
2019-03-31
2019-03-05 2250.21 未披露 定期报告 2019-02-28
2019-03-05 2246.60 未披露
更多>>
from December 31, 2017 to December 31, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock Issuance of ESPP Settlement of restricted stock Conversion of preferred stock to common stock
2018-12-31
2018-11-13 2141.15 未披露 定期报告 2018-10-31
2018-11-13 2141.10 未披露
更多>>
From December 31, 2017 TO September 30, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock in connection with our IPO Conversion of preferred stock to common stock Settlement of restricted stock
2018-09-30
2018-08-14 2129.72 未披露 定期报告 2018-08-13
2018-08-14 2031.60 未披露
更多>>
From December 31, 2017 TO June 30, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock in connection with our IPO Conversion of preferred stock to common stock
2018-06-30
2018-05-10 2026.41 未披露 定期报告 2018-04-30
2018-05-10 2022.60 未披露
更多>>
From December 31, 2017 to March 31, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock in connection with our IPO Conversion of preferred stock to common stock
2018-03-31
2018-03-19 1999.57 未披露 定期报告 2018-02-28
2018-02-09 1951.96 未披露
更多>>
1.Common stock offered by Cardlytics 5,400,000 shares 2.The number of shares of our common stock that will be outstanding after this offering is based on 14,119,619 shares of common stock outstanding as of December 31, 2017 3.a one-for-four reverse stock split of our common stock effected on January 26, 2018
2018-02-09
2018-03-19 1411.96 未披露
更多>>
from December 31, 2016 to December 31, 2017 Conversion of convertible promissory notes to common stock Exercise of common stock options
2017-12-31
2018-01-12 1418.87 未披露 定期报告 2017-09-30
From June 30, 2025 to September 30, 2025 Settlement of restricted stock
From March 31, 2025 to June 30, 2025 Issuance of common stock pursuant to the 2018 ESPP (as defined below) Settlement of restricted stock
From December 31, 2024 to March 31, 2025 Settlement of restricted stock
From December 31, 2023 to December 31, 2024 Issuance of restricted stock Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) Exercise of common stock options Issuance of common stock, net of issuance cost Issuance of common stock pursuant to the 2018 ESPP (as defined below)
From June 30, 2024 to September 30, 2024 Settlement of restricted stock
From March 31, 2024 to June 30, 2024 Issuance of common stock pursuant to the 2018 ESPP (as defined below) Settlement of restricted stock
From December 31, 2023 to March 31, 2024 Issuance of common stock, net of issuance costs - ATM Offering Program (as defined below) Exercise of common stock options Settlement of restricted stock Issuance of common stock, net of issuance costs - Settlement Agreement (as defined below)
From December 31,2022 to December 31,2023 Exercise of common stock options Issuance of restricted stock Issuance of common stock Issuance of common stock under the ESPP
From June 30, 2023 to September 30, 2023 Exercise of common stock options Settlement of restricted stock
From December 31, 2021 to December 31, 2022 Exercise of common stock options Issuance of restricted stock Common stock to be issued for the acquisition of Entertainment Issuance of common stock under the ESPP Repurchase and Cancellation of common stock
From June 30, 2022 to September 30, 2022 Settlement of restricted stock
From March 31, 2022 to June 30, 2022 Exercise of common stock options Settlement of restricted stock Issuance of common stock pursuant to the ESPP Repurchase and cancellation of common stock
From December 31, 2021 to March 31, 2022 Exercise of common stock options Settlement of restricted stock Common stock purchase consideration for the acquisition of Entertainment
From December 31, 2020 to December 31, 2021 Exercise of common stock options Issuance of restricted stock Issuance of common stock Common stock purchase consideration for the acquisition of Dosh Issuance of ESPP
From June 30, 2021 to September 30, 2021 Exercise of common stock options Settlement of restricted stock Common stock purchase consideration for the acquisition of Dosh
From December 31, 2020 to June 30, 2021 Issuance of restricted stock Issuance of common stock Issuance of common stock pursuant to the ESPP Common stock purchase consideration for the acquisition of Dosh
from December 31, 2020 to March 31, 2021 Exercise of common stock options Issuance of restricted stock Issuance of common stock
1.Common Stock offered by the company 3,850,000 shares. 2.The number of shares of common stock to be outstanding after this offering is based on 27,860,729 shares of common stock outstanding as of December 31, 2020.
From December 31, 2019 to December 31, 2020 Exercise of common stock options Exercise of common stock warrants Issuance of restricted stock Issuance of ESPP
From June 30, 2020 to September 30, 2020 Exercise of common stock options Settlement of restricted stock
From March 31, 2020 to June 30, 2020 Exercise of common stock options Settlement of restricted stock Issuance of common stock pursuant to the ESPP
From December 31, 2019 to March 31, 2020 Exercise of common stock options Exercise of common stock warrants Settlement of restricted stock
from December 31, 2018 to December 31, 2019 Exercise of common stock options Exercise of common stock warrants Issuance of restricted stock Issuance of common stock Issuance of ESPP
from June 30, 2019 to September 30, 2019 Exercise of common stock options Exercise of common stock warrants Settlement of restricted stock Issuance of common stock
from March 31, 2019 to June 30,2019 Issuance of ESPP Exercise of common stock options Settlement of restricted stock
from December 31, 2018 to March 31, 2019 Exercise of common stock options Settlement of restricted stock
from December 31, 2017 to December 31, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock Issuance of ESPP Settlement of restricted stock Conversion of preferred stock to common stock
From December 31, 2017 TO September 30, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock in connection with our IPO Conversion of preferred stock to common stock Settlement of restricted stock
From December 31, 2017 TO June 30, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock in connection with our IPO Conversion of preferred stock to common stock
From December 31, 2017 to March 31, 2018 Exercise of common stock options Exercise of common stock warrants Issuance of common stock in connection with our IPO Conversion of preferred stock to common stock
1.Common stock offered by Cardlytics 5,400,000 shares 2.The number of shares of our common stock that will be outstanding after this offering is based on 14,119,619 shares of common stock outstanding as of December 31, 2017 3.a one-for-four reverse stock split of our common stock effected on January 26, 2018
from December 31, 2016 to December 31, 2017 Conversion of convertible promissory notes to common stock Exercise of common stock options